Literature DB >> 30527240

Histologic pattern of invasion and epithelial-mesenchymal phenotype predict prognosis in squamous carcinoma of the head and neck.

Gregory T Wolf1, William Winter2, Emily Bellile3, Ariane Nguyen2, C R Donnelly4, Jonathan B McHugh5, Dafydd Thomas5, Lahin Amlani2, Laura Rozek6, Yu L Lei4.   

Abstract

INTRODUCTION: Disruption of E-cadherin function and increased expression of vimentin and the transcriptional oncogene, SOX2, are thought to characterize epithelial to mesenchymal transition (EMT) in HNSCC that contributes to invasive and metastatic behavior. To determine if such changes relate to prognosis or host immune response, expression of these markers and correlations with clinical characteristics, histologic worst pattern of invasion (WPOI) and tumor infiltrating lymphocytes (TIL) and survival were assessed.
METHODS: Immunohistologic expression of markers was determined in tissue microarrays from 274 previously untreated HNSCC patients. Expression was correlated with levels of TILs in microcores and WPOI in biopsy specimens. Correlations were assessed by Kruskal-Wallis testing and Spearman correlation coefficients where appropriate. Overall and relapse-free survival were analyzed with Cox proportional hazards models. Median follow up was 60.0 months.
RESULTS: Loss of E-cadherin expression was significantly associated with low or absent SOX2 expression (R = 0.433, p < 0.0001). SOX2 expression and low grade WPOI were significantly associated with favorable overall (OS) and relapse free (RFS) survival in multivariable analysis. E-cadherin expression did not correlate with TILs, however WPOI score correlated indirectly with CD4, CD8, and FoxP3 levels. When grouped by primary treatment, lower grades (1, 2) of WPOI predicted improved RFS and OS in patients treated with primary surgery but not for patients treated with chemoradiation.
CONCLUSION: The findings suggest that SOX2 expression and WPOI are significant prognostic factors and that WPOI correlates with decreased T cell infiltration. The combination of markers and TILs might be useful in selecting patients for primary surgery. Published by Elsevier Ltd.

Entities:  

Keywords:  E-cadherin; Head and neck cancer; Pattern of invasion; SOX2; Survival; Vimentin

Mesh:

Substances:

Year:  2018        PMID: 30527240      PMCID: PMC6293994          DOI: 10.1016/j.oraloncology.2018.10.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  46 in total

1.  Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Authors:  Rebecca Hoesli; Andrew C Birkeland; Andrew J Rosko; Mohamad Issa; Kelsey L Chow; Nicole L Michmerhuizen; Jacqueline E Mann; Steven B Chinn; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; J Chad Brenner; Matthew E Spector
Journal:  Oral Oncol       Date:  2017-12-23       Impact factor: 5.337

2.  EMT in cancer.

Authors:  Thomas Brabletz; Raghu Kalluri; M Angela Nieto; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

3.  Surgical margins in the genomic era: The Hayes Martin Lecture, 2012.

Authors:  Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-11

4.  Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma.

Authors:  Yufeng Li; Shuting Bai; William Carroll; Dan Dayan; Joseph C Dort; Keith Heller; George Jour; Harold Lau; Carla Penner; Michael Prystowsky; Eben Rosenthal; Nicolas F Schlecht; Richard V Smith; Mark Urken; Marilena Vered; Beverly Wang; Bruce Wenig; Abdissa Negassa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-12-19

5.  Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Authors:  Andreas Schröck; Maike Bode; Friederike Johanna Maria Göke; Petra Marion Bareiss; Rebekka Schairer; Hui Wang; Wilko Weichert; Alina Franzen; Robert Kirsten; Tobias van Bremen; Angela Queisser; Glen Kristiansen; Lynn Heasley; Friedrich Bootz; Claudia Lengerke; Sven Perner
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

6.  Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.

Authors:  Maria Fernanda Setúbal Destro Rodrigues; Flávia Caló de Aquino Xavier; Nathália Paiva Andrade; Camila Lopes; Lucyene Miguita Luiz; Bruno Tavares Sedassari; Ana Melissa Ccopa Ibarra; Rossana Verónica Mendoza López; Claudia Kliemann Schmerling; Raquel Ajub Moyses; Eloiza Elena Tajara da Silva; Fabio Daumas Nunes
Journal:  Head Neck       Date:  2018-04-01       Impact factor: 3.147

7.  Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.

Authors:  Gregory T Wolf; Douglas B Chepeha; Emily Bellile; Ariane Nguyen; Daffyd Thomas; Jonathan McHugh
Journal:  Oral Oncol       Date:  2014-10-03       Impact factor: 5.337

8.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.

Authors:  Chie Kudo-Saito; Hiromi Shirako; Tadashi Takeuchi; Yutaka Kawakami
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

Review 9.  Epithelial to mesenchymal transition in head and neck squamous cell carcinoma.

Authors:  Ashley Smith; Theodoros N Teknos; Quintin Pan
Journal:  Oral Oncol       Date:  2012-11-19       Impact factor: 5.337

10.  Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion.

Authors:  S Islam; T E Carey; G T Wolf; M J Wheelock; K R Johnson
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

View more
  1 in total

1.  Using quantitative parameters derived from pretreatment dual-energy computed tomography to predict histopathologic features in head and neck squamous cell carcinoma.

Authors:  Hesong Shen; Yuanying Huang; Xiaoqian Yuan; Daihong Liu; Chunrong Tu; Yu Wang; Xiaoqin Li; Xiaoxia Wang; Qiuzhi Chen; Jiuquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.